Differences

This shows you the differences between two versions of the page.

--- home:diseases:ibd [02.17.2019] – [Inflammatory bowel disease (Crohn's disease and ulcerative colitis)] sallieq
+++ home:diseases:ibd [03.13.2019] – [Research] sallieq
@@ Line 4: / Line 4: @@
-<relatedarticle> [[home:diseases:ibs|Irritable bowel syndrome]] </article>
+<relatedarticles> [[home:diseases:ibs|Irritable bowel syndrome]], [[home:diseases:celiac|Celiac disease]] </article>
 ===== Introduction =====
@@ Line 181: / Line 181: @@
 ===== Research =====
+Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pubmed>long:25023670}}))
+In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pubmed>long:25947920}}))
 Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.  (({{pubmed>long:25557335}}))

home/diseases/ibd.txt · Last modified: 09.14.2022 by 127.0.0.1